Table 3. Clinical characteristics and CTC detection of patients with tumor recurrence or radionecrosis.
| No. | Age | Sex | Diagnosis | Region | Surgery | CT | RT (IMRT) | month after RT | KPS | rCBV | CTC count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 44 | M | GBM | right parietal | STR | TMZ | 60Gy/30Fr | 5 | 90 | 0.56 | 0 |
| 2 | 45 | M | GBM | left frontal | GTR | TMZ | 60Gy/30Fr | 13 | 90 | 2.38 | 2 |
| 3 | 46 | F | AA | right frontal | GTR | TMZ | 60Gy/30Fr | 29 | 80 | 0.67 | 8 |
| 4 | 31 | M | AOA | right frontal | GTR | TMZ | 60Gy/30Fr | 8 | 90 | 0.65 | 0 |
| 5 | 45 | F | GBM | left parieto- occipital | GTR | TMZ | 60Gy/28Fr | 6 | 70 | 2.27 | 3 |
Abbreviations: CT, chemotherapy; RT, radiotherapy; AA, anaplastic astrocytoma; AOA, anaplastic oligoastrocytoma; GBM, glioblastoma multiforme; KPS, Karnofsky performance scale; IMRT, intensity modulated radiation therapy; TMZ, temozolomide.